Michael J Georgetson, MD, FACG, FASGE
Guthrie Provider
- Gastroenterology and Hepatology
- Guthrie Corning Hospital
- Guthrie Robert Packer Hospital
- Guthrie Troy Community Hospital
Appointments & Contact
Offers Telemedicine Visits
Information Icon
Telemedicine video visits make it easier to find care at a time and location that is convenient for you. Telemedicine appointments are available for both new patient visits and follow-ups.
Clinical Interests
- Colonoscopy
- Dysphagia
- Endoscopy
- Enteroscopy
- ERCP - Endoscopic Retrograde Cholangiopancreatography
- Esophageal Diseases
- Esophageal Disorders and Swallowing Difficulties
- Gastroesophageal Reflux Disease (GERD)
- Gastrointestinal Bleeding
- Gastrointestional Neoplasia
- Therapeutic Colonoscopy
- Therapeutic Endoscopy
Locations
- Also Offers Telemedicine Information Icon866-488-4743Telemedicine video visits make it easier to find care at a time and location that is convenient for you. Telemedicine appointments are available for both new patient visits and follow-ups.
- Also Offers Telemedicine Information Icon866-488-4743Telemedicine video visits make it easier to find care at a time and location that is convenient for you. Telemedicine appointments are available for both new patient visits and follow-ups.
Education
- Jefferson Medical College, Philadelphia, Pa.
- Guthrie Robert Packer Hospital, Sayre, Pa.
- Guthrie Robert Packer Hospital, Sayre, Pa.
- Fellow of the American College of Gastroenterology (FACG)
- American Board of Internal Medicine (Gastroenterology)
News & Video
Clinical Trials
- A Phase 2, Dose-finding, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Efavaleukin Alfa Induction Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of the Efficacy, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4)
- Cultivate-APD334-202: A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn's Disease
- Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI)
- Limited access protocol for the use of oral cisapride in the treatment of refractory gastroesophageal reflux disease and other gastrointestinal motility disorders. CIS-USA-154
Patient Comments